Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide

Blood Cancer Journal, Published online: 26 March 2024; doi:10.1038/s41408-024-01039-1Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide

Source: Blood Cancer Journal - March 26, 2024 Category: Hematology Authors: Utkarsh Goel Charalampos Charalampous Prashant Kapoor Moritz Binder Francis K. Buadi David Dingli Angela Dispenzieri Amie Fonder Morie A. Gertz Wilson I. Gonsalves Suzanne R. Hayman Miriam A. Hobbs Yi L. Hwa Taxiarchis Kourelis Martha Q. Lacy Nelson Leung Source Type: research